{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T15:30:39Z","timestamp":1696174239122},"reference-count":36,"publisher":"Elsevier BV","issue":"1-4","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostaglandins & Other Lipid Mediators"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.prostaglandins.2011.07.004","type":"journal-article","created":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T21:09:18Z","timestamp":1312232958000},"page":"84-89","source":"Crossref","is-referenced-by-count":1,"title":["Inhibition of epoxy-eicosanoid degradation improves the tocolytic effects of indomethacin in the uterus from pregnant women"],"prefix":"10.1016","volume":"96","author":[{"given":"St\u00e9phanie","family":"Corriveau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryse","family":"Berthiaume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Charles","family":"Pasquier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prostaglandins.2011.07.004_bib0005","unstructured":"Public Health Agency of Canada. Canadian perinatal health report; 2003."},{"key":"10.1016\/j.prostaglandins.2011.07.004_bib0010","first-page":"1","article-title":"Births final data for 2004","volume":"55","author":"Martin","year":"2006","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.prostaglandins.2011.07.004_bib0015","first-page":"1","article-title":"Births: final data for 2005","volume":"56","author":"Martin","year":"2007","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.prostaglandins.2011.07.004_bib0020","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0002-9378(95)90163-9","article-title":"Fetal cardiac function and ductus arteriosus during indomethacin and sulindac therapy for threatened preterm labor: a randomized study","volume":"173","author":"Rasanen","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.prostaglandins.2011.07.004_bib0025","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.1471-0528.2002.01518.x","article-title":"In vitro study of tocolytic effect of rofecoxib, a specific cyclo-oxygenase 2 inhibitor. comparison and combination with other tocolytic agents","volume":"109","author":"Doret","year":"2002","journal-title":"BJOG"},{"key":"10.1016\/j.prostaglandins.2011.07.004_bib0030","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/AOG.0b013e3181b48336","article-title":"Society for maternal\u2013fetal medicine. Magnesium sulfate for preterm labor and preterm birth","volume":"114","author":"Mercer","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.prostaglandins.2011.07.004_bib0185","series-title":"New frontiers in smooth muscle biology and physiology","first-page":"291","article-title":"EETs and 20-HETE modulate smooth muscle reactivity and other metabolic processes","author":"Rousseau","year":"2007"},{"key":"10.1016\/j.prostaglandins.2011.07.004_bib0040","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1161\/01.RES.79.4.784","article-title":"Functional implications of a newly characterized pathway of 11,12-epoxyeicosatrienoic acid metabolism in arterial smooth muscle","volume":"79","author":"Fang","year":"1996","journal-title":"Circ Res"},{"key":"10.1016\/j.prostaglandins.2011.07.004_bib0045","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1540\/jsmr.41.175","article-title":"Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system","volume":"41","author":"Miyata","year":"2005","journal-title":"J Smooth Muscle Res"},{"key":"10.1016\/j.prostaglandins.2011.07.004_bib0050","doi-asserted-by":"crossref","first-page":"420.e1","DOI":"10.1016\/j.ajog.2009.07.047","article-title":"Why eicosanoids could represent a new class of tocolytics on uterine activity in pregnant women","volume":"201","author":"Corriveau","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl.","key":"10.1016\/j.prostaglandins.2011.07.004_bib0055","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1194\/jlr.R800038-JLR200","article-title":"Arachidonic acid cytochrome P450 epoxygenase pathway","volume":"50","author":"Spector","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.prostaglandins.2011.07.004_bib0060","doi-asserted-by":"crossref","first-page":"E647","DOI":"10.1152\/ajpendo.00227.2009","article-title":"Detection of EETs and HETE-generating cytochrome P-450 enzymes and the effects of their metabolites on myometrial and vascular function","volume":"297","author":"Pearson","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.prostaglandins.2011.07.004_bib0065","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.coph.2009.12.002","article-title":"Pharmacological inhibition of the soluble epoxide hydrolase-from mouse to man","volume":"10","author":"Revermann","year":"2010","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.prostaglandins.2011.07.004_bib0070","first-page":"849","article-title":"Increased concentrations of arachidonic acid lipoxygenase metabolites in amniotic fluid during parturition","volume":"70","author":"Romero","year":"1987","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.prostaglandins.2011.07.004_bib0075","first-page":"1","article-title":"A new class of mediators of immediate hypersensitivity reactions and inflammation","volume":"11","author":"Samuelsson","year":"1983","journal-title":"Adv Prostaglandin Thromboxane Leukot Res"},{"key":"10.1016\/j.prostaglandins.2011.07.004_bib0080","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/0090-6980(85)90164-9","article-title":"Myometrial activity of the term pregnant uterus","volume":"30","author":"Bryman","year":"1985","journal-title":"Prostaglandins"},{"key":"10.1016\/j.prostaglandins.2011.07.004_bib0085","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.prostaglandins.2006.08.003","article-title":"Endogenous prostaglandins regulate spontaneous contractile activity of uterine strips isolated from non-pregnant pigs","volume":"81","author":"Cao","year":"2006","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.prostaglandins.2011.07.004_bib0090","doi-asserted-by":"crossref","first-page":"266.e1","DOI":"10.1016\/j.ajog.2010.06.009","article-title":"Lipoxygenase and cyclooxygenase inhibitors reveal a complementary role of arachidonic acid derivatives in pregnant human myometrium","volume":"203","author":"Corriveau","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.prostaglandins.2011.07.004_bib0095","doi-asserted-by":"crossref","first-page":"261.e1","DOI":"10.1016\/j.ajog.2010.05.029","article-title":"Effect of maternal body mass index on in vitro response to tocolytics in term myometrium","volume":"203","author":"Chiossi","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.prostaglandins.2011.07.004_bib0100","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1471-0528.2006.01233.x","article-title":"Poor uterine contractility in obese women","volume":"114","author":"Zhang","year":"2007","journal-title":"BJOG"},{"key":"10.1016\/j.prostaglandins.2011.07.004_bib0105","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.pharmtox.38.1.97","article-title":"Cyclooxygenases 1 and 2","volume":"38","author":"Vane","year":"1998","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.prostaglandins.2011.07.004_bib0110","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1210\/jc.85.9.3468","article-title":"Expression of cyclooxygenase-2 and prostanoid receptors by human myometrium","volume":"85","author":"Erkinheimo","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.prostaglandins.2011.07.004_bib0115","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1210\/jc.75.4.1027","article-title":"Contractile effects of prostaglandins, oxytocin, and endothelin-1 in human myometrium in vitro: refractoriness of myometrial tissue of pregnant women to prostaglandins E2 and F2 alpha","volume":"75","author":"Word","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.prostaglandins.2011.07.004_bib0120","first-page":"174","article-title":"In vitro contractile response of human myometrium to oxytocin, PGF2alpha, bradykinin and ET-1","volume":"108","author":"Janicek","year":"2007","journal-title":"Bratisl Lek Listy"},{"key":"10.1016\/j.prostaglandins.2011.07.004_bib0125","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00404-010-1365-9","article-title":"The onset of human parturition","volume":"281","author":"Kamel","year":"2010","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.prostaglandins.2011.07.004_bib0130","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.jpedsurg.2004.04.006","article-title":"In situ inhibition of uterine activity by indomethacin: possible relevance to preterm labor prevention after fetal surgery","volume":"39","author":"Garza","year":"2004","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.prostaglandins.2011.07.004_bib0135","doi-asserted-by":"crossref","first-page":"L1037","DOI":"10.1152\/ajplung.00145.2007","article-title":"Functional effects of 20-HETE on human bronchi: hyperpolarization and relaxation due to BKCa channel activation","volume":"293","author":"Morin","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.prostaglandins.2011.07.004_bib0140","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1165\/rcmb.2007-0232OC","article-title":"EET displays anti-inflammatory effects in TNF-alpha stimulated human bronchi: putative role of CPI-17","volume":"38","author":"Morin","year":"2008","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.prostaglandins.2011.07.004_bib0145","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1165\/rcmb.2008-0177RC","article-title":"CPI-17 silencing-reduced responsiveness in control and TNF-alpha-treated human bronchi","volume":"39","author":"Morin","year":"2008","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.prostaglandins.2011.07.004_bib0150","article-title":"DHA derivative prevents inflammation and hyperreactivity in lung: Implication of CPI-17 in asthma","author":"Morin","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.prostaglandins.2011.07.004_bib0155","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1124\/mol.105.015263","article-title":"Double feature at the signalplex","volume":"68","author":"Neve","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.prostaglandins.2011.07.004_bib0160","doi-asserted-by":"crossref","first-page":"13646","DOI":"10.1073\/pnas.0605908103","article-title":"Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors","volume":"103","author":"Schmelzer","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.prostaglandins.2011.07.004_bib0165","doi-asserted-by":"crossref","first-page":"5893","DOI":"10.1073\/pnas.87.15.5893","article-title":"Endogenous biosynthesis of arachidonic acid epoxides in humans: Increased formation in pregnancy-induced hypertension","volume":"87","author":"Catella","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.prostaglandins.2011.07.004_bib0170","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1124\/jpet.105.085605","article-title":"Activation of peroxisome proliferator-activated receptor alpha by substituted urea-derived soluble epoxide hydrolase inhibitors","volume":"314","author":"Fang","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.prostaglandins.2011.07.004_bib0175","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1124\/jpet.106.103556","article-title":"Substituted adamantyl-urea inhibitors of the soluble epoxide hydrolase dilate mesenteric resistance vessels","volume":"318","author":"Olearczyk","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.prostaglandins.2011.07.004_bib0180","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1517\/13543776.2010.484804","article-title":"Soluble epoxide hydrolase inhibitors: a patent review","volume":"20","author":"Shen","year":"2010","journal-title":"Expert Opin Ther Pat"}],"container-title":["Prostaglandins & Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882311000669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882311000669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,21]],"date-time":"2020-06-21T22:49:15Z","timestamp":1592779755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882311000669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":36,"journal-issue":{"issue":"1-4","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S1098882311000669"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2011.07.004","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}